metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Meningococcal disease: Can we predict the unpredictable?
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial article
Meningococcal disease: Can we predict the unpredictable?
Enfermedad meningocócica: ¿podemos predecir lo impredecible?
Federico Martinón-Torresa,b,
Corresponding author
, Antoni Trillac
a Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
b Grupo de Genética, Vacunas, Infecciones y Pediatría, Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
c Servicio de Medicina Preventiva y Epidemiología, Hospital Clinic - Universidad de Barcelona - ISGlobal
Read
3
Times
was read the article
1
Total PDF
2
Total HTML
Share statistics
 array:24 [
  "pii" => "S2387020619305170"
  "issn" => "23870206"
  "doi" => "10.1016/j.medcle.2019.04.029"
  "estado" => "S300"
  "fechaPublicacion" => "2020-01-10"
  "aid" => "4895"
  "copyright" => "Elsevier España, S.L.U.. All rights reserved"
  "copyrightAnyo" => "2019"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "Med Clin. 2020;154:20-2"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0025775319304130"
      "issn" => "00257753"
      "doi" => "10.1016/j.medcli.2019.04.035"
      "estado" => "S300"
      "fechaPublicacion" => "2020-01-10"
      "aid" => "4895"
      "copyright" => "Elsevier España, S.L.U."
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "sco"
      "cita" => "Med Clin. 2020;154:20-2"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 5
        "formatos" => array:2 [
          "HTML" => 1
          "PDF" => 4
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "Enfermedad meningoc&#243;cica&#58; &#191;podemos predecir lo impredecible&#63;"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "20"
            "paginaFinal" => "22"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Meningococcal disease&#58; Can we predict the unpredictable&#63;"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Federico Martin&#243;n-Torres, Antoni Trilla"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Federico"
                "apellidos" => "Martin&#243;n-Torres"
              ]
              1 => array:2 [
                "nombre" => "Antoni"
                "apellidos" => "Trilla"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2387020619305170"
          "doi" => "10.1016/j.medcle.2019.04.029"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020619305170?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775319304130?idApp=UINPBA00004N"
      "url" => "/00257753/0000015400000001/v2_202001222045/S0025775319304130/v2_202001222045/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2387020619305273"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2019.08.003"
    "estado" => "S300"
    "fechaPublicacion" => "2020-01-10"
    "aid" => "5017"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Med Clin. 2020;154:23-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>"
      "titulo" => "Occupational cancer&#58; A hidden reality and an awaiting challenge"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "23"
          "paginaFinal" => "28"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "El c&#225;ncer ocupacional&#58; una realidad oculta y un desaf&#237;o pendiente"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0020"
          "etiqueta" => "Fig&#46; 4"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr4.jpeg"
              "Alto" => 916
              "Ancho" => 2083
              "Tamanyo" => 119213
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0020"
              "detalle" => "Fig&#46; "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Evolution of the number occupational cancer cases reported&#46;</p> <p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Prepared by authors&#46; Source&#58; Ministry of Labour&#44; Migration and Social Security&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a></p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Marcos Larrosa Moles, Bego&#241;a Mart&#237;nez-Jarreta"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Marcos"
              "apellidos" => "Larrosa Moles"
            ]
            1 => array:2 [
              "nombre" => "Bego&#241;a"
              "apellidos" => "Mart&#237;nez-Jarreta"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0025775319306165"
        "doi" => "10.1016/j.medcli.2019.08.005"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775319306165?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020619305273?idApp=UINPBA00004N"
    "url" => "/23870206/0000015400000001/v2_202002131702/S2387020619305273/v2_202002131702/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2387020619305133"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2018.12.022"
    "estado" => "S300"
    "fechaPublicacion" => "2020-01-10"
    "aid" => "4746"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Med Clin. 2020;154:16-9"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Brief report</span>"
      "titulo" => "Therapeutic erythroapheresis&#58; Experience in patients with polycythemia vera and secondary erythrocytosis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "16"
          "paginaFinal" => "19"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Eritroaf&#233;resis terap&#233;utica&#58; experiencia en pacientes con policitemia vera y eritrocitosis secundaria"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 944
              "Ancho" => 1561
              "Tamanyo" => 159979
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Haematocrit values before and after carrying out TE in each patient&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ingrid Parra Salinas, Valle Recasens Flores, Mar&#237;a &#193;ngeles Monta&#241;&#233;s, Jos&#233; Antonio Garc&#237;a-Erce"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Ingrid"
              "apellidos" => "Parra Salinas"
            ]
            1 => array:2 [
              "nombre" => "Valle"
              "apellidos" => "Recasens Flores"
            ]
            2 => array:2 [
              "nombre" => "Mar&#237;a &#193;ngeles"
              "apellidos" => "Monta&#241;&#233;s"
            ]
            3 => array:2 [
              "nombre" => "Jos&#233; Antonio"
              "apellidos" => "Garc&#237;a-Erce"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0025775319300284"
        "doi" => "10.1016/j.medcli.2018.12.016"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775319300284?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020619305133?idApp=UINPBA00004N"
    "url" => "/23870206/0000015400000001/v2_202002131702/S2387020619305133/v2_202002131702/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial article</span>"
    "titulo" => "Meningococcal disease&#58; Can we predict the unpredictable&#63;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "20"
        "paginaFinal" => "22"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Federico Martin&#243;n-Torres, Antoni Trilla"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Federico"
            "apellidos" => "Martin&#243;n-Torres"
            "email" => array:1 [
              0 => "federico.martinon.torres@sergas.es"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Antoni"
            "apellidos" => "Trilla"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Pediatr&#237;a&#44; Hospital Cl&#237;nico Universitario de Santiago de Compostela&#44; Santiago de Compostela&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Grupo de Gen&#233;tica&#44; Vacunas&#44; Infecciones y Pediatr&#237;a&#44; Instituto de Investigaci&#243;n Sanitaria de Santiago&#44; Universidad de Santiago de Compostela&#44; Santiago de Compostela&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Medicina Preventiva y Epidemiolog&#237;a&#44; Hospital Clinic - Universidad de Barcelona - ISGlobal"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Enfermedad meningoc&#243;cica&#58; &#191;podemos predecir lo impredecible&#63;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">By using vaccinations&#44; we can prevent all forms of invasive meningococcal disease&#44; an epidemiologically unpredictable infection&#44; which sometimes occurs as epidemic outbreaks&#44; whose fatality rates in recent decades have not changed&#44; killing one in ten affected patients &#40;mortality rate in Spain&#58; 12&#46;7 &#37;&#44; 2017&#8211;2018&#41; and which can have serious and disabling consequences for survivors &#40;amputations&#44; deafness&#44; neurological deficits&#41; in a percentage that is never lower than 10 &#37;&#44; and which can reach up to 30 &#37;&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#8211;3</span></a> Meningococcal disease carries a significant and often underestimated burden of disease&#44; which includes psychological sequela for the patient and their families&#59; the financial costs of required assistance and rehabilitation&#59; the expenses of managing a public health crisis that each case may involve&#44; and the costs arising from possible complaints by those affected&#44; among others&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> We also do not take into account the cost of &#8216;fear of disease&#8217;&#58; How many consultations to the health system are made &#8220;in case its meningitis&#8221;&#63; How many complementary tests&#44; empirical treatments&#44; or observation admissions do healthcare professionals prescribe in case the patient could have a meningococcal disease&#63;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> A careful assessment of these aspects may find a balance in the decision-making process of whether to include a vaccine in the schedule&#44; as occurred in the United Kingdom&#44; a country that initially decided not to include the serogroup B meningococcal vaccine and that subsequently reversed that decision&#44; becoming the first country to systematically vaccinate all infants against meningococcus&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> This is in significant contrast with a recent report by the Spanish Ministry of Health&#44; which once again relied on the efficiency criterion to reject the inclusion of the meningococcal B vaccine in the Spanish universal schedule&#44; using cost-effectiveness calculations that were criticised in 2013 because they were thought of as insufficient<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> and which remain obsolete today&#44; considering the new data available on this vaccine&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;6&#44;7</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Spain has significant problems with meningococcal disease&#58; 1&#41; serogroup B&#44; which is the cause of the majority of cases occurring today and throughout the last decade&#44; and that is still the main strain&#44; despite being partially controlled by individual and optional private vaccination&#44; and 2&#41; the increase in serogroups W and Y&#44; in particular the 2013 UK variant of serogroup W&#44; a hypervirulent strain with a lethality close to 30 &#37;&#44; which is wreaking havoc in the EU and already circulating in Spain with a rapid increase in the number of cases&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">To a large extent&#44; we are conditioned by what the British dictate in regards to the prevention of meningococcal disease&#44; as the United Kingdom is pioneer in the introduction of new meningococcal vaccines in the schedule&#46; Despite the data that this country provides on the effectiveness of vaccinations against meningococcus B&#44; the interpretation that the Spanish health authorities have made so far is different&#58; they have not only not included the vaccine against meningococcus B in the vaccination schedule&#44; a decision that could be understood if only the criterion of &#8216;classical&#8217; efficiency is considered&#44; but&#44; surprisingly&#44; they question the vaccine itself&#46; Preliminary data from the United Kingdom showed - within 10 months of starting the vaccination campaign &#8211; a 50 &#37; impact on the vaccinated cohort but not on the other age groups&#44; with an estimated vaccine effectiveness of close to 90 &#37;&#44; although with wide confidence intervals&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8&#44;9</span></a> In the programme&#39;s third year&#44; the decrease in cases was 60 &#37;&#44; with an effectiveness of 70 &#37; against any meningococcus B and 88 &#37; against type B meningococci that express antigens contained in the vaccine&#46; Because meningococcal disease has a low incidence rate and it has a vaccine coverage that is greater than 90 &#37;&#44; estimating vaccination effectiveness and whether that value is statistically significant is difficult&#44; especially since the unvaccinated population numbers are so low&#46; In this context&#44; measuring the vaccine impact &#40;the actual reduction in cases of the disease&#44; which is what really matters in terms of public health&#41; is much more indicative&#46; Thus&#44; the United Kingdom estimates that it has prevented no less than 250 cases since it included the meningococcal B vaccine on the schedule three years ago&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> In Spain&#44; the National Network for Epidemiological Surveillance registered a greater reduction than expected in cases of meningococcus B since the vaccine was made available&#44; attributable to the vaccine coverage achieved despite not being financed by National Health System&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Spain could estimate the effectiveness of the vaccine against meningococcus B&#44; since approximately half the infants that receive the vaccine do so through private health insurance and the other half have not been vaccinated&#46; This is an important figure&#44; but to calculate it&#44; all the autonomous regions would have to be coordinated simultaneously&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The British experience leaves no room for any speculation about the safety of the meningococcal B vaccine&#44; analysing more than three million children vaccinated&#46;<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10&#8211;12</span></a> The greater reactogenicity of the vaccine when co-administered with routine vaccines in infants has not had a significant impact on the health system&#44; where it is the general practitioner who sees children&#44; nor on the acceptance of the vaccine by the population&#46; Spanish paediatricians use it&#44; and a lot&#44; without any significant problems&#46; Even so&#44; there are still aspects related to the meningococcal B vaccine that we do not fully understand&#44; such as its effect on carriers or what the real duration of clinical protection is&#44;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> both issues of added value but not necessary conditions of usefulness&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">With regard to serogroups W and Y&#44; Spain&#39;s Interterritorial Council recently decided &#40;March 2019&#41; to start vaccination with the quadrivalent meningococcal ACWY-CRM conjugate vaccine&#44; replacing the adolescent dose of the meningococcal C and accompanying that measure with a vaccination rescue plan which must include six cohorts &#40;up to 18 years&#41; in 2&#8211;3 years&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> This is a significant measure similar to the one initiated by the United Kingdom in 2015&#44; and which seems to be working well&#44; according to the impact observed three years later &#40;50 cases prevented&#41;&#44; and this despite the difficulties of reaching high coverage in a population that is difficult to access&#44; as is the adolescent group&#46;<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10&#44;14</span></a> However&#44; certain nuances must be mentioned&#58; Will we be able to develop this measure in Spain simultaneously in all autonomous communities and reach a high level of coverage to control the disease through the extensive and maintained vaccination of adolescents&#44; the main reservoir of the disease&#63; Do all autonomous communities really have the resources to carry out rescue vaccination in a coordinated manner&#44; essential for that measure to be successful in the short-medium term&#63; Can we prevent cases in infants produced by a strain that has special attraction to this age&#63;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The time between the first autonomous community to vaccinate against ACWY &#40;Castilla y Le&#243;n&#44; January 2019&#41; and the others &#40;Asturias&#44; Valencia and Madrid&#44; June 2019&#41; will be six months&#44; with the deadline to start vaccinating being the entire 2020&#46; We still do not know when and how the rescue plan will begin&#46; Meanwhile&#44; cases of meningococcal W disease have doubled over the past year&#44; and that upward trend remains and has increased during 2019&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">And what about infants&#63; Stating that in Spain there are few cases of meningococcal serogroup W disease in infants&#44; a group where the incidence rate is maximum&#44; is true but misleading&#58; the British speculate that the decrease observed in cases of serogroup W disease in young children &#40;aged 1&#8211;4&#41; is most likely due to the cross-protection that the meningococcal B vaccine provides and not so much the indirect effect of the ACWY reservoir vaccination&#44; which has only begun to be observed at all ages after four years of vaccination and the once the rescue plan was completed&#46; This statement is based on the presence of the meningococcal B vaccine antigens that are common to the circulating British strain W&#44; and that the impact observed in young children and adolescents is not initially recorded in other ages&#46; With Spain&#39;s current real coverage&#44; the meningococcal B vaccine could also have this effect and thus explain why the number of cases in infants has not increased so significantly&#46; In any case&#44; the data from the meningococcal B vaccine leave no room for scepticism&#44; we can no longer put off or argue against its inclusion on the vaccination schedule by claiming insufficient data on the one hand&#44; and on the other accept the expected benefits &#8216;of class&#8217;&#44; in terms of the effect that the ACWY vaccine can have on carriers of serogroups W and Y&#44; even though direct evidence in this regard is still limited&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15&#8211;17</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">If we were forced to choose&#44; the Dutch option of vaccination against ACWY would be the most preferable and perhaps the most realistic in a country with autonomous regions such as Spain&#44; with a public health system whose decision-making authority and administration is slow&#46; Following this option&#44; adolescents would be vaccinated for a medium-term control of the disease&#44; but direct immediate protection of infants would also be carried out&#44; where the incidence of serogroup W is higher and in which indirect protection will take years to be noticed&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> Moreover&#44; we could speculate that by acting on the meningococcal reservoir in infants &#8211; less than in the adolescent group&#44; but not negligible &#8211; we could also reduce the number of cases in the elderly&#58; Spain&#39;s social reality means that many of these infants and children&#8217;s caregivers&#8217; are their grandparents&#44; so it seems very likely that children are the elderly&#39;s main source of contagion&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Meningococcal disease is unpredictable&#44; both epidemiologically and clinically&#46; We know that not everyone is equally vulnerable to the disease<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">19&#44;20</span></a> but we are not yet able to use this information to guide a individualised preventive or therapeutic strategy&#46; The only way to control and reduce meningococcal disease is through the systematic vaccination of the population&#44; i&#46;e&#46; including vaccines in the schedule&#46; In this context&#44; the pressure exerted by epidemiological&#44; social&#44; expert&#44; scientific societies and pharmaceutical laboratories opinion&#44; and now also by the active election campaign itself&#44; act as catalysts in the decision-making process&#46; Regardless of any other connotation&#44; Castilla y Le&#243;n has made the most complete&#44; determined and administrative commitment to end the meningococcal disease in its autonomous community&#44; by adopting a vaccination schedule that is even better than the British one&#44; and that includes the protection of infants against meningococcus B and ACWY&#44; in addition to vaccination against ACWY in adolescents&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">The fact is that in Spain&#44; and in Europe &#8211; where the income levels and the quality of the health systems are high &#8211; the majority of children &#40;fortunately few in absolute terms&#41; who have been admitted or died as a result of a serious infection have done so due to causes that could have been prevented by vaccination&#44; and that deserves reflection&#46;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a> The investment in vaccines in the Spanish health budget as a whole is proportionally very low &#40;0&#46;4 &#37; of total public health expenditure&#41;&#44; a fact that suggests a lack of perspective in assessing the role of vaccines as a medium- and long-term health instrument by those who manage health resources&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> This might be an excellent opportunity to rethink the current decision-making process in reference to vaccines in Spain&#44; acknowledging the work done until now&#44; but working towards the future without presumptions or acrimony&#44; strengthening a unique&#44; modern&#44; agile and accepted vaccination schedule in solidarity with everyone&#46; The British model &#40;<span class="elsevierStyleItalic">Joint Committee on Vaccination and Immunisation</span>&#41; is a good reference&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> The <span class="elsevierStyleItalic">Joint Committee on Vaccination and Immunisation</span> is an independent Committee that advises the British Government&#44; endowed with an excellent Code of Good Practice&#44; a degree of transparency and an inclusiveness of all the different actors involved in all its processes that is remarkable&#46; In the specific case of the meningococcal B vaccine&#44; the <span class="elsevierStyleItalic">Joint Committee on Vaccination and Immunisation</span> was able to go beyond counting deaths and disabilities in a timely manner and considered all other costs and evidence in a balanced manner&#46; The British Government accepted its recommendation and was able to arrive at an excellent economic agreement on the price of the vaccine with the producing laboratory&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Analysing the Spanish reality in its context&#44; we believe that there are lessons to be learned from the past&#44; and that we now have the opportunity to better&#44; more effectively and equitably protect our entire population&#44; not only against what is already inevitable&#44; but also against what might emerge from a disease that is as unpredictable and potentially serious as meningococcal disease&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interest</span><p id="par0060" class="elsevierStylePara elsevierViewall">FMT has received fees as a consultant&#47;advisor and&#47;or speaker from Pfizer&#44; GlaxoSmithKline&#44; Sanofi Pasteur MSD&#44; Merck&#44; Sanofi Pasteur&#44; Novartis&#44; Novavax&#44; and Seqirus&#44; and has participated as a researcher in research studies and&#47;or clinical trials with vaccines for Pfizer&#44; GlaxoSmithKline&#44; Sanofi Pasteur MSD&#44; Merck&#44; Sanofi Pasteur&#44; Novartis&#44; Novavax&#44; Regeneron&#44; Seqirus and MedImmune Inc&#46;&#44; the funds from which were paid to his institution&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">AT has received fees as a consultant&#47;advisor and&#47;or speaker from GlaxoSmithKline&#44; MSD&#44; Sanofi Pasteur and Seqirus&#44; and has participated as a researcher in clinical trials with vaccines for Pfizer&#44; GlaxoSmithKline&#44; Sanofi Pasteur and MSD&#44; the funds from which were paid to his institution&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflict of interest"
        ]
        1 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Martin&#243;n-Torres F&#44; Trilla A&#46; Enfermedad meningoc&#243;cica&#58; &#191;podemos predecir lo impredecible&#63; Med Clin &#40;Barc&#41;&#46; 2020&#59;154&#58;20&#8211;22&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:22 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recomendaciones de vacunaci&#243;n frente a enfermedad meningoc&#243;cica invasiva&#46; Comisi&#243;n de Salud P&#250;blica del Consejo Interterritorial del Sistema Nacional de Salud"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Grupo de trabajo vacunaci&#243;n frente a EMI de la Ponencia de Programa y Registro de Vacunaciones"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:2 [
                        "fecha" => "2019"
                        "editorial" => "Ministerio de Sanidad&#44; Consumo y Bienestar Social&#44; marzo"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Deciphering the burden of meningococcal disease&#58; conventional and under-recognized elements"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Martinon-Torres"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jadohealth.2016.03.041"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Adolesc Health&#46;"
                        "fecha" => "2016"
                        "volumen" => "59"
                        "numero" => "2 Suppl"
                        "paginaInicial" => "S12"
                        "paginaFinal" => "20"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27449145"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The burden of pediatric invasive meningococcal disease in Spain &#40;2008-2013&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "I&#46; Rivero-Calle"
                            1 => "L&#46; Vilanova-Trillo"
                            2 => "J&#46; Pardo-Seco"
                            3 => "L&#46;B&#46; Salvado"
                            4 => "L&#46;I&#46; Quinteiro"
                            5 => "F&#46; Martinon-Torres"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/INF.0000000000001048"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Infect Dis J&#46;"
                        "fecha" => "2016"
                        "volumen" => "35"
                        "paginaInicial" => "407"
                        "paginaFinal" => "413"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26974748"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vaccine evaluation&#58; lessons from a meningococcal B vaccine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Sarfatti"
                            1 => "F&#46; Martinon-Torres"
                            2 => "S&#46; Nadel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/archdischild-2014-306030"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dis Child&#46;"
                        "fecha" => "2015"
                        "volumen" => "100"
                        "paginaInicial" => "514"
                        "paginaFinal" => "516"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25670403"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Immunisation against meningococcus B&#58; the case of Spain"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Martinon-Torres"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(13)62322-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet&#46;"
                        "fecha" => "2013"
                        "volumen" => "382"
                        "paginaInicial" => "1552"
                        "paginaFinal" => "1553"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24209825"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Las vacunas en Espa&#241;a&#58; Situaci&#243;n actual y perspectivas de futuro"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Deloitte"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:2 [
                        "fecha" => "2017"
                        "editorial" => "Noviembre"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Enfermedad meningoc&#243;cica&#44; Vigilancia de la temporada 2017-2018&#46; Resultados de la Red Nacional de Vigilancia Epidemiol&#243;gica&#46; Available from&#58; <a target="_blank" href="http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/fd-enfermedades-prevenibles-vacunacion/pdf_2019/RENAVE_EMI-2017-18.pdf">http&#58;&#47;&#47;www&#46;isciii&#46;es&#47;ISCIII&#47;es&#47;contenidos&#47;fd-servicios-cientifico-tecnicos&#47;fd-vigilancias-alertas&#47;fd-enfermedades&#47;fd-enfermedades-prevenibles-vacunacion&#47;pdf&#95;2019&#47;RENAVE&#95;EMI-2017-18&#46;pdf</a> &#40;last accessed Mar 2019&#41;&#46;"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Growing evidence supports 4CMenB effectiveness"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46;N&#46; Ladhani"
                            1 => "R&#46; Borrow"
                            2 => "N&#46;J&#46; Andrews"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1473-3099(18)30051-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Infect Dis&#46;"
                        "fecha" => "2018"
                        "volumen" => "18"
                        "paginaInicial" => "370"
                        "paginaFinal" => "371"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29371069"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England&#58; a national observational cohort study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;R&#46; Parikh"
                            1 => "N&#46;J&#46; Andrews"
                            2 => "K&#46; Beebeejaun"
                            3 => "H&#46; Campbell"
                            4 => "S&#46; Ribeiro"
                            5 => "C&#46; Ward"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(16)31921-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet&#46;"
                        "fecha" => "2016"
                        "volumen" => "388"
                        "paginaInicial" => "2775"
                        "paginaFinal" => "2782"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28100432"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Joint Committee on Vaccination and Immunisation of United Kingdom&#46;Minute of the meeting on 03 October 2018&#46; Available from&#58; <a target="_blank" href="https://app.box.com/s/iddfb4ppwkmtjusir2tc">https&#58;&#47;&#47;app&#46;box&#46;com&#47;s&#47;iddfb4ppwkmtjusir2tc</a> &#40;last accessed Mar 2019&#41;&#46;"
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Reassuring safety data from the UK multicomponent meningococcal group B vaccine &#40;4CMenB&#41; programme"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46;A&#46; Bettinger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S2352-4642(18)30135-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Child Adolesc Health&#46;"
                        "fecha" => "2018"
                        "volumen" => "2"
                        "paginaInicial" => "380"
                        "paginaFinal" => "381"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30169274"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety of multicomponent meningococcal group B vaccine &#40;4CMenB&#41; in routine infant immunisation in the UK&#58; a prospective surveillance study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Bryan"
                            1 => "S&#46; Seabroke"
                            2 => "J&#46; Wong"
                            3 => "K&#46; Donegan"
                            4 => "E&#46; Webb"
                            5 => "C&#46; Goldsmith"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S2352-4642(18)30103-2"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Child Adolesc Health&#46;"
                        "fecha" => "2018"
                        "volumen" => "2"
                        "paginaInicial" => "395"
                        "paginaFinal" => "403"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30169281"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Persistence of the immune response after 4CMenB vaccination&#44;and the response to an additional booster dose in infants&#44; children&#44; adolescents&#44; and young adults"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "F&#46; Martin&#243;n-Torres"
                            1 => "T&#46; Nolan"
                            2 => "D&#46; Toneatto"
                            3 => "A&#46; Banzhoff"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4161/hv.23606"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hum Vaccin Immunother"
                        "fecha" => "2019"
                        "volumen" => "9"
                        "paginaInicial" => "1"
                        "paginaFinal" => "12"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23442580"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Emergency meningococcal ACWY vaccination program for teenagers to control group W meningococcal disease&#44; England&#44; 2015&#8211;2016"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "H&#46; Campbell"
                            1 => "M&#46; Edelstein"
                            2 => "N&#46; Andrews"
                            3 => "R&#46; Borrow"
                            4 => "M&#46; Ramsay"
                            5 => "S&#46; Ladhani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3201/eid2307.170236"
                      "Revista" => array:6 [
                        "tituloSerie" => "Emerg Infect Dis&#46;"
                        "fecha" => "2017"
                        "volumen" => "23"
                        "paginaInicial" => "1184"
                        "paginaFinal" => "1187"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28409739"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Limited impact of adolescent meningococcal ACWY vaccination on Neisseria meningitidis Serogroup W carriage in university students"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "N&#46;J&#46; Oldfield"
                            1 => "L&#46;R&#46; Green"
                            2 => "J&#46; Parkhill"
                            3 => "C&#46;D&#46; Bayliss"
                            4 => "D&#46;P&#46;J&#46; Turner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/infdis/jix596"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Infect Dis&#46;"
                        "fecha" => "2018"
                        "volumen" => "217"
                        "paginaInicial" => "608"
                        "paginaFinal" => "616"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29155998"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A phase III observer-blind randomized&#44; controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;C&#46; Read"
                            1 => "P&#46; Dull"
                            2 => "X&#46; Bai"
                            3 => "K&#46; Nolan"
                            4 => "J&#46; Findlow"
                            5 => "R&#46; Bazaz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.vaccine.2016.11.071"
                      "Revista" => array:6 [
                        "tituloSerie" => "Vaccine&#46;"
                        "fecha" => "2017"
                        "volumen" => "35"
                        "paginaInicial" => "427"
                        "paginaFinal" => "434"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27912986"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage&#58; an observer-blind&#44; phase 3 randomised clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;C&#46; Read"
                            1 => "D&#46; Baxter"
                            2 => "D&#46;R&#46; Chadwick"
                            3 => "S&#46;N&#46; Faust"
                            4 => "A&#46; Finn"
                            5 => "S&#46;B&#46; Gordon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(14)60842-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet&#46;"
                        "fecha" => "2014"
                        "volumen" => "384"
                        "paginaInicial" => "2123"
                        "paginaFinal" => "2131"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25145775"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease&#44; the Netherlands&#44; 2018"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46;J&#46; Knol"
                            1 => "W&#46;L&#46; Ruijs"
                            2 => "L&#46; Antonise-Kamp"
                            3 => "H&#46;E&#46; de Melker"
                            4 => "A&#46; van der Ende"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Euro Surveill&#46;"
                        "fecha" => "2018"
                        "volumen" => "23"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Davila"
                            1 => "V&#46;J&#46; Wright"
                            2 => "C&#46;C&#46; Khor"
                            3 => "K&#46;S&#46; Sim"
                            4 => "A&#46; Binder"
                            5 => "W&#46;B&#46; Breunis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ng.640"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Genet"
                        "fecha" => "2010"
                        "volumen" => "42"
                        "paginaInicial" => "772"
                        "paginaFinal" => "776"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20694013"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Natural resistance to Meningococcal Disease related to CFH loci&#58; meta-analysis of genome-wide association studies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Martinon-Torres"
                            1 => "E&#46; Png"
                            2 => "C&#46;C&#46; Khor"
                            3 => "S&#46; Davila"
                            4 => "V&#46;J&#46; Wright"
                            5 => "K&#46;S&#46; Sim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/srep35842"
                      "Revista" => array:5 [
                        "tituloSerie" => "Sci Rep&#46;"
                        "fecha" => "2016"
                        "volumen" => "6"
                        "paginaInicial" => "35842"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27805046"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Life-threatening infections in children in Europe &#40;the EUCLIDS Project&#41;&#58; a prospective cohort study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Martinon-Torres"
                            1 => "A&#46; Salas"
                            2 => "I&#46; Rivero-Calle"
                            3 => "M&#46; Cebey-L&#243;pez"
                            4 => "J&#46; Pardo-Seco"
                            5 => "J&#46;A&#46; Herberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S2352-4642(18)30113-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Child Adolesc Health&#46;"
                        "fecha" => "2018"
                        "volumen" => "2"
                        "paginaInicial" => "404"
                        "paginaFinal" => "414"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30169282"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Joint Committee on Vaccination and Immunisation <a target="_blank" href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation">https&#58;&#47;&#47;www&#46;gov&#46;uk&#47;government&#47;groups&#47;joint-committee-on-vaccination-and-immunisation</a> &#40;&#250;ltima consulta&#58; Abril 2019&#41;&#46;"
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23870206/0000015400000001/v2_202002131702/S2387020619305170/v2_202002131702/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "46797"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Editorial article"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015400000001/v2_202002131702/S2387020619305170/v2_202002131702/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020619305170?idApp=UINPBA00004N"
]
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2021 March 2 1 3

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos